Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Perhaps A Question for Letter?

Re: "Strategic Partnership"? pautaotzu

posted on Jan 23, 2008 12:27PM

It would appear that you've come full circle from suggesting a possible business partnership with the J's by which

 

TPL could offer the retail shareholder  500% times the current pps.

5 x .40 = $2/sh

 

I don't think any court in Delaware would see a problem with that offer.

 

To now agreeing

 

That would not be fair to us, but the Sony deal wasn't all that fair to us.

 

Which is why I don't believe the business resolution is structured in the way you suggest. I would go further and suggest that in my humble opinion, the business resolution means simply that the Defendants in Marshall have licensed the MMP Portfolio, nothing more, nothing less.

 

 

Be well

 

 

Share
New Message
Please login to post a reply